Two years of hope.
I sunk money into this 2 years ago. Yes, hopefully to make some money, but I also liked where the company was headed with the research.
I don’t analyze charts, trends, basics, etc. when it comes to ILNS. If I did, I would have an ulcer.
Legal court proceedings and the board’s shenanigans with stock maneuvers aside, the possibility of a new drug or 2 for a very debilitating disease still exists.
It may be years down the road before we see the results, but I will continue to have faith in the science of ILNS, even if their leaders drive it into the deep end of the cesspool when it comes to financial matters.
ABM
